Sandbox Reserved 971: Difference between revisions

Revision as of 21:26, 8 January 2015 view source Caroline Cuer (talk \| contribs) 92 edits No edit summary ← Older edit		Revision as of 21:27, 8 January 2015 view source Caroline Cuer (talk \| contribs) 92 edits No edit summary Newer edit →
Line 7:		Line 7:

	In 2005, IL-33 was identified as a ligand for the transmembrane receptor ST2 (also known as [http://www.ncbi.nlm.nih.gov/gene/9173 IL1RL1] and it IL-1 receptor accessory protein (IL-1RAcP) as you see below, both members of the [http://www.ncbi.nlm.nih.gov/pubmed/17027517 interleukin-1 receptor family]. IL-33/ST2 signaling is involved in T-cell immune responses.		In 2005, IL-33 was identified as a ligand for the transmembrane receptor ST2 (also known as [http://www.ncbi.nlm.nih.gov/gene/9173 IL1RL1] and it IL-1 receptor accessory protein (IL-1RAcP) as you see below, both members of the [http://www.ncbi.nlm.nih.gov/pubmed/17027517 interleukin-1 receptor family]. IL-33/ST2 signaling is involved in T-cell immune responses.
	[[Image:IL33_with_its_receptor.png]]		[[Image:IL33_with_its_receptor.png\|400px]]

Navigation menu